Halozyme Therapeutics shares owned by HoyleCohen
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by HoyleCohen
from 13F filings
Historical chart of HoyleCohen investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by HoyleCohen consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by HoyleCohen
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $209k | 4.0k | 52.36 |
| 2023-12-31 | $324k | 8.8k | 36.96 |
| 2023-09-30 | $309k | 8.1k | 38.20 |
| 2023-06-30 | $292k | 8.1k | 36.07 |
| 2023-03-31 | $309k | 8.1k | 38.19 |
| 2022-12-31 | $461k | 8.1k | 56.90 |
| 2022-09-30 | $293k | 7.4k | 39.59 |
| 2022-06-30 | $326k | 7.4k | 44.05 |
| 2022-03-31 | $295k | 7.4k | 39.86 |
| 2021-12-31 | $298k | 7.4k | 40.27 |
| 2021-09-30 | $301k | 7.4k | 40.68 |
| 2021-06-30 | $336k | 7.4k | 45.41 |
| 2021-03-31 | $309k | 7.4k | 41.76 |
| 2020-12-31 | $316k | 7.4k | 42.70 |